STA-1

DRUG2 trials

Sponsors

Sinphar Pharmaceutical Co., Ltd

Conditions

Alzheimer DiseaseVascular Dementia

Phase 2

Study of STA-1 as an Add-on Treatment to Donepezil

Sinphar Pharmaceutical Co., LtdAlzheimer Disease

Start: 2015-12-31Target: 136Updated: 2014-08-20

Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)

CompletedNCT01475578

Sinphar Pharmaceutical Co., LtdVascular Dementia

Start: 2002-03-31End: 2002-10-31Updated: 2011-11-21